Literature DB >> 22321667

Differentiating first episode substance induced and primary psychotic disorders with concurrent substance use in young people.

Samantha Fraser1, Leanne Hides, Lisa Philips, Dawn Proctor, Dan I Lubman.   

Abstract

OBJECTIVE: Substance use is common in first-episode psychosis, and complicates the accurate diagnosis and treatment of the disorder. The differentiation of substance-induced psychotic disorders (SIPD) from primary psychotic disorders (PPD) is particularly challenging. This cross-sectional study compares the clinical, substance use and functional characteristics of substance using first episode psychosis patients diagnosed with a SIPD and PPD.
METHOD: Participants were 61 young people (15-24 years) admitted to a psychiatric inpatient service with first episode psychosis, reporting substance use in the past month. Diagnosis was determined using the Psychiatric Research Interview for DSM-IV Substance and Mental disorders (PRISM-IV). Measures of clinical (severity of psychotic symptoms, level of insight, history of trauma), substance use (frequency/quantity, severity) and social and occupational functioning were also administered.
RESULTS: The PRISM-IV differentially diagnosed 56% of first episode patients with a SIPD and 44% with a PPD. Those with a SIPD had higher rates of substance use and disorders, higher levels of insight, were more likely to have a forensic and trauma history and had more severe hostility and anxious symptoms than those with a PPD. Logistic regression analysis indicated a family history of psychosis, trauma history and current cannabis dependence were the strongest predictors of a SIPD. Almost 80% of diagnostic predictions of a SIPD were accurate using this model.
CONCLUSIONS: This clinical profile of SIPD could help to facilitate the accurate diagnosis and treatment of SIPD versus PPD in young people with first episode psychosis admitted to an inpatient psychiatric service. Copyright Â
© 2012 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 22321667     DOI: 10.1016/j.schres.2012.01.022

Source DB:  PubMed          Journal:  Schizophr Res        ISSN: 0920-9964            Impact factor:   4.939


  4 in total

Review 1.  Substance-induced Psychosis in Youth.

Authors:  David Beckmann; Kelsey Leigh Lowman; Jessica Nargiso; James McKowen; Lisa Watt; Amy M Yule
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2019-09-23

2.  Where to seek help? Barriers to beginning treatment during the first-episode psychosis.

Authors:  Isabela Dos Santos Martin; Bianca Cristina Ciccone Giacon; Kelly Graziani Giacchero Vedana; Ana Carolina Guidorizzi Zanetti; Lorena Fendrich; Sueli Aparecida Frari Galera
Journal:  Int J Nurs Sci       Date:  2018-06-30

3.  Symptom Profiles in Psychotic Disorder Not Otherwise Specified.

Authors:  Line Widing; Carmen Simonsen; Camilla B Flaaten; Beathe Haatveit; Ruth Kristine Vik; Kristin F Wold; Gina Åsbø; Torill Ueland; Ingrid Melle
Journal:  Front Psychiatry       Date:  2020-11-12       Impact factor: 4.157

4.  Treated incidence and baseline characteristics of substance induced psychosis in a Norwegian catchment area.

Authors:  Melissa A Weibell; Inge Joa; Jørgen Bramness; Jan Olav Johannessen; Patrick D McGorry; Wenche Ten Velden Hegelstad; Tor Ketil Larsen
Journal:  BMC Psychiatry       Date:  2013-11-27       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.